Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00186641 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

High Dose Chemotherapy and Autologous Transplant for Breast Cancer

StatusCompleted
PhasePhase 2
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Active, Not Recruiting to Completed Enrollment target: 203 · Primary completion date: Feb 8, 2008 · Completion date: Mar 2005 to Feb 8, 2008v6 Show all 4 changesShow less
    • Enrollment target: 203
    • Primary completion date: Feb 8, 2008
    • Completion date: Mar 2005 to Feb 8, 2008
  2. 4 versions Re-verified since Jun 13, 2006, no change to tracked fieldsv2-v5
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Trial Details
NCT Number NCT00186641
Lead Sponsor Stanford University
Conditions Graft vs Host Disease
Enrollment 203 participants
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov